
Chun Chao
Research Scientist at kp-scalresearch.org
Articles
-
1 month ago |
acsjournals.onlinelibrary.wiley.com | Chun Chao |Hui Zhou |Dov Shalman |Katherine Pak
DATA AVAILABILITY STATEMENT Anonymized data that support the findings of this study may be made available from the corresponding author on reasonable request from qualified researchers with documented evidence of training for human subjects protections.
-
2 months ago |
today.line.me | Chun Chao
被譽為「地表最強音樂節」,Coachella不只是音樂迷朝聖的殿堂,更是流行文化、經濟效應與全球趨勢的縮影。以下用6點帶你認識Coachella,從為何2025年超過6成觀眾選擇分期付款,到Lady Gaga、Lisa、Jennie等巨星全力登台的原因。延伸閱讀:Lisa 2025 Coachella「盔甲裝」設計師是他!Asher Levine怪誕美學CNN也專文報導Coachella介紹1.
-
Mar 6, 2025 |
ajmc.com | Brooke McCormick |Chun Chao
In the final part of The American Journal of Managed Care®'sinterview with Chun Chao, PhD, MS, cancer epidemiologist at Kaiser Permanente Southern California, she suggests areas for further research into the COVID-19 pandemic's impact on ovarian cancer outcomes. Chao also shares key lessons from the COVID-19 pandemic on how to maintain positive outcomes for insured patients with ovarian cancer during future public health emergencies.
-
Mar 3, 2025 |
ajmc.com | Brooke McCormick |Chun Chao
In part 2 of this interview with Chun Chao, PhD, MS, cancer epidemiologist at Kaiser Permanente Southern California, she tells The American Journal of Managed Care® about the key findings and limitations of her study, "Clinical Remission Rates in Patients With Epithelial Ovarian Cancer Before and After the Onset of the COVID-19 Pandemic in an Integrated Healthcare Delivery System." Watch part 1 for insights into the study's background and objectives.
-
Feb 27, 2025 |
ajmc.com | Brooke McCormick |Chun Chao
In part 1 of an interview with The American Journal of Managed Care®, Chun Chao, PhD, MS, cancer epidemiologist at Kaiser Permanente Southern California, explores the impact of the COVID-19 pandemic on oncology care, particularly for patients with ovarian cancer.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →